W1625
Waymouth MB 752/1 Medium
With L-glutamine, without sodium bicarbonate, powder, suitable for cell culture
Synonym(s):
Waymouth Medium, Waymouth′s medium
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.75
UNSPSC Code:
12352207
Application
For the cultivation of mouse L929 cells in a serum-free environment. Also used in whole organ culture, establishment of carcinoma cell lines from pleural effusions, and the growth of potentially tumorigenic cells prior to their assessment in vitro.
Preparation Note
Formulated to contain 14.0 grams of powder per liter of medium.
Supplement with 2.2 g/L sodium bicarbonate.
Storage Class
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Waymouth MB 752/1 Medium Formulation
Instructions
Differential expression of extracellular matrix-mediated pathways in single-suture craniosynostosis.
Brendan D Stamper et al.
PloS one, 6(10), e26557-e26557 (2011-10-27)
Craniosynostosis is a disease defined by premature fusion of one or more cranial sutures. The mechanistic pathology of single-suture craniosynostosis is complex and while a number of genetic biomarkers and environmental predispositions have been identified, in many cases the causes
Gul Ozcan et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology, 21(6), 1552-1560 (2017-01-01)
Cancer is a long process that leads the organism to death and is associated with the normal cells acquiring the ability to divide permanently. Nowadays, the use of natural products in cancer therapy has a great importance. In addition, working
Tala Shekarian et al.
Science translational medicine, 11(515) (2019-10-28)
Although immune checkpoint-targeted therapies are currently revolutionizing cancer care, only a minority of patients develop durable objective responses to anti-PD-1, PD-L1, and CTLA-4 therapy. Therefore, new therapeutic interventions are needed to increase the immunogenicity of tumors and overcome the resistance
Global Trade Item Number
| SKU | GTIN |
|---|---|
| W1625-10X1L | 04061837488658 |